Showing results (1711-1720 of 1,865) with videos related to

Sort By:
Pageof 187
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|December 6, 2021
[Efficacy of a recombinant bovine basic fibroblast growth factor gel for the treatment of moderate dry eye: a multicenter randomized double-blind parallel controlled clinical trial]C H Huang, Z G Liu, M C Zhang, et al.
Neoplasma|June 27, 2018
Carfilzomib combined with ex vivo-expanded patient autologous natural killer cells for myeloma immunotherapyS K Chang, J Hou, G G Chen, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 16, 2026
[Efficacy analysis of tumor necrosis factor inhibitors in the treatment of chronic recurrent multifocal osteomyelitis]T Yue, J M Lai, J Zhu, et al.
Cell Death and Differentiation|May 17, 2014
Phage display discovery of novel molecular targets in glioblastoma-initiating cellsJ K Liu, D Lubelski, D L Schonberg, et al.
Cancer Research|January 25, 2005
Perinucleolar compartment prevalence has an independent prognostic value for breast cancerRajesh V Kamath, Ann D Thor, Chen Wang, et al.
Neurology and Therapy|April 15, 2021
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache CentersElizabeth Faust, Irina Pivneva, Karen Yang, et al.
Journal of Endocrinological Investigation|February 20, 2016
Analysis of the association between plasma PCSK9 and Lp(a) in Han ChineseS-H Yang, S Li, Y Zhang, et al.
Acta Anaesthesiologica Scandinavica|October 6, 1997
Retardation of pain development: a case of recovery from congenital insensitivity to painT H Zhou, X H Ren, D L Yin, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|January 29, 2018
[Progress in research of family-based cohort study on common chronic non-communicable diseases in rural population in northern China]M Y Wang, X Tang, X Y Qin, et al.
Clinical Medicine Insights. Oncology|April 1, 2026
Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective ReviewMatheus Sewastjanow-Silva, Mok Oh, Lawrence Chang, et al.
Pageof 187